SCHEMBL6520126

SCHEMBL6520126

COc1ccc(N)c(CCNC2CCN(C(=O)OC(C)(C)C)CC2F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.47
ALDH1A1 P00352 1/20 0.44
STS P08842 2/20 0.43
MAPT P10636 2/20 0.42
TP53 P04637 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41
SRC P12931 2/20 0.41
ABL1 P00519 1/20 0.41
EGFR P00533 1/20 0.41
ABL2 P42684 1/20 0.41
TGFBR1 P36897 2/20 0.40
BACE1 P56817 2/20 0.40
CTSD P07339 1/20 0.40
CTSE P14091 1/20 0.40
DPP4 P27487 1/20 0.39
HTT P42858 1/20 0.39
MMP1 P03956 1/20 0.39
MMP3 P08254 1/20 0.39
MMP7 P09237 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6517994 0.91 EPHX2 (0.46) EPHX2ALDH1A1STSMAPTTP53
SCHEMBL6525624 0.86 EPHX2 (0.44) EPHX2ALDH1A1STSMAPTTP53
SCHEMBL3656515 0.86 EPHX2 (0.36) EPHX2ALDH1A1STSMAPTTP53
SCHEMBL30178331 0.85 ALDH1A1 (0.56) EPHX2ALDH1A1STSMAPTTP53
SCHEMBL15752192 0.81 HTR1A (0.36) MAPT
SCHEMBL3657873 0.79 EPHX2 (0.35) EPHX2ALDH1A1STSMAPTTP53
SCHEMBL6525187 0.77 EPHX2 (0.43) EPHX2ALDH1A1STSMAPTTP53
SCHEMBL3652372 0.76 ALDH1A1 (0.52) EPHX2ALDH1A1STSMAPTTP53
SCHEMBL3652370 0.76 ALDH1A1 (0.52) EPHX2ALDH1A1STSMAPTTP53
SCHEMBL4321000 0.76 ALDH1A1 (0.52) EPHX2ALDH1A1STSMAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8629137-B2 CGRP antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-14 US disclosed
US-8629137-B2 CGRP antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-01-14 US disclosed
US-20130029975-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-31 US disclosed
US-20110059954-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-03-10 US disclosed
WO-2009050232-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110059954-A1 CGRP ANTAGONISTS CALCRL, CALCR, CALCA EPHX2 1486/4885ALDH1A1 1292/4885STS 4062/4885
US-20130029975-A1 CGRP ANTAGONISTS CALCRL, CALCR, CALCA EPHX2 1486/4885ALDH1A1 1292/4885STS 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.